Harnessing the Power of Immune Tolerance in Living-Donor Kidney Transplant
powernephron
Published on Dec 8, 2022
Joe Leventhal, MD, PhD
Fowler McCormick Professor of Surgery
Director, Kidney Transplant Program
Associate Director, Pancreas Transplant Program
Northwestern University
Feinberg School of Medicine
www.glomcon.org
www.edu.glomcon.org
www.pubs.glomcon.org
Category
Add to
Please Sign In or Create Account to use this feature!
Flag Video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
Watch Later
45:18Onconephrology Updates: Immune Checkpoint Inhibitors and Kidney Injury
16 views 834 days ago -
Watch Later
29:13 -
Watch Later
29:03Abbal Koirala, MD - Rituximab in the management of MCD and immune mediated FSGS
17 views 787 days ago -
Watch Later
!["Not Again! Recurrent Disease After Kidney Transplant", by Priya Verghese, MD, MPH]()
51:21"Not Again! Recurrent Disease After Kidney Transplant", by Priya Verghese, MD, MPH
12 views 792 days ago -
Watch Later
![Risk Factors Associated with Post-Kidney Transplant Malignancy]()
57:45Risk Factors Associated with Post-Kidney Transplant Malignancy
13 views 792 days ago -
Watch Later
![Recurrent FSGS: What’s New? - UCSF Kidney Transplant Program - Update in Transplantation 2013]()
33:04
